Northern Trust Corp Magenta Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.62 - $0.79 $16,040 - $20,438	-25,872 Reduced 26.58%	71,463 $54,000
Q1 2023 May 15, 2023	BUY	$0.41 - $0.86 $4,396 - $9,222	10,724 Added 12.38%	97,335 $76,000
Q3 2022 Nov 14, 2022	BUY	$1.26 - $2.09 $548 - $909	435 Added 0.5%	86,611 $122,000
Q2 2022 Aug 12, 2022	SELL	$0.97 - $3.08 $201,633 - $640,239	-207,870 Reduced 70.69%	86,176 $103,000
Q1 2022 May 13, 2022	SELL	$2.55 - $5.23 $38,836 - $79,652	-15,230 Reduced 4.92%	294,046 $853,000
Q4 2021 Feb 08, 2022	BUY	$4.43 - $8.33 $30,496 - $57,343	6,884 Added 2.28%	309,276 $1.37 Million
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $99,098 - $161,464	-16,326 Reduced 5.12%	302,392 $2.2 Million
Q2 2021 Aug 13, 2021	BUY	$9.76 - $14.15 $602,631 - $873,691	61,745 Added 24.03%	318,718 $3.12 Million
Q1 2021 May 12, 2021	SELL	$7.66 - $13.38 $280,991 - $490,818	-36,683 Reduced 12.49%	256,973 $3.04 Million
Q4 2020 Feb 11, 2021	SELL	$6.1 - $7.94 $1,592 - $2,072	-261 Reduced 0.09%	293,656 $2.3 Million
Q3 2020 Nov 16, 2020	BUY	$6.52 - $8.94 $209,187 - $286,830	32,084 Added 12.25%	293,917 $2 Million
Q2 2020 Aug 14, 2020	BUY	$6.18 - $10.76 $206,751 - $359,975	33,455 Added 14.65%	261,833 $1.97 Million
Q1 2020 May 14, 2020	SELL	$6.03 - $15.24 $13,464 - $34,030	-2,233 Reduced 0.97%	228,378 $1.43 Million
Q4 2019 Feb 14, 2020	SELL	$9.07 - $15.84 $37,985 - $66,337	-4,188 Reduced 1.78%	230,611 $3.5 Million
Q3 2019 Nov 13, 2019	BUY	$9.63 - $14.0 $500,740 - $727,972	51,998 Added 28.45%	234,799 $2.41 Million
Q2 2019 Aug 13, 2019	BUY	$13.4 - $17.67 $356,641 - $470,287	26,615 Added 17.04%	182,801 $2.7 Million
Q1 2019 May 13, 2019	BUY	$5.7 - $19.7 $511,700 - $1.77 Million	89,772 Added 135.17%	156,186 $2.57 Million
Q4 2018 Feb 12, 2019	BUY	$5.57 - $11.65 $66,244 - $138,553	11,893 Added 21.81%	66,414 $378,000
Q3 2018 Nov 14, 2018	BUY	$11.32 - $15.7 $466,995 - $647,687	41,254 Added 310.95%	54,521 $655,000
Q2 2018 Sep 18, 2018	BUY	$13.5 - $14.52 $179,104 - $192,636	13,267 New	13,267 $179,000

Others Institutions Holding MGTA

# of Institutions

Shares Held

442K

Call Options Held

Put Options Held

Hellman Jordan Management CO Inc Quincy, MA

441K
Shares

$0
0.3% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.3K
Shares

$0
0.0% of portfolio

View Full List

About Magenta Therapeutics, Inc.

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

More about MGTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account